Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K151243
    Manufacturer
    Date Cleared
    2015-08-20

    (101 days)

    Product Code
    Regulation Number
    876.4020
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    STRYKER INFRARED ILLUMINATION SYSTEM (IRIS) [AIM Light Source and IRIS Ureteral Kit]

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Stryker AIM Light Source is intended to trans-illuminate anatomical structures during open or laparoscopic surgical procedures.

    The Stryker® AIM Light Source and SafeLight Cable are indicated for use to provide real-time endoscopic visible and near-infrared fluorescence imaging. The Stryker® AIM Light Source and SafeLight Cable enable surgeons to perform minimally invasive surgery using standard endoscope visible light as well as visual assessment of vessels, blood flow and related tissue perfusion, and at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct and common hepatic duct), using near infrared imaging.

    Fluorescence imaging of biliary ducts with the Stryker® AIM Light Source and SafeLight Cable are intended for use with standard of care white light and, when indicated, intraoperative cholangiography. The devices are not intended for standalone use for biliary duct visualization.

    The Stryker IRIS Ureteral Kit when used with compatible Stryker is intended to trans-illuminate the ureter during surgical procedures. The catheter accepts up to 0.038" guide wire. The kit can be used for either open surgical or laparoscopic procedures.

    Device Description

    The Stryker® Infrared Illuminating System (IRIS) is used to trans-illuminate the ureter during laparoscopic or open surgical procedures. Trans-illumination is intended to help the surgeon identify the ureter(s) during open or laparoscopic surgical procedure of lower abdomen or pelvic areas. The Stryker® Infrared Illuminating System (IRIS) consists of the following main components (herein referred to as 'proposed devices'):

    • A light source console.
    • A Ureteral Kit that consists of two catheters, one fiber assembly containing two light emitting fibers, one catheter dispenser, one light emitting fiber dispenser, two luer connectors, and two drape clips.
    AI/ML Overview

    This document is a 510(k) premarket notification for the Stryker® Infrared Illuminating System (IRIS). It's a regulatory submission to the FDA, demonstrating substantial equivalence to previously cleared devices. It does not contain a study that proves the device meets acceptance criteria in the format you requested, typically found in clinical trial reports or detailed performance studies.

    The document primarily focuses on demonstrating that the new device, IRIS, is substantially equivalent to existing predicate devices (Stryker Ureteral Illumination System IV and Stryker® Infrared Fluorescence Imaging System) in terms of its indications for use, design technology, and performance specifications.

    Here's an analysis based on the provided text, addressing your questions where information is available, and noting when it's not:

    1. Table of acceptance criteria and reported device performance:

    The document mentions "Bench performance testing was conducted to ensure that the devices functioned as intended and met design specifications and acceptance criteria." and "Cadaver testing validated the ureteral trans-illumination capability of the Stryker Infrared Illuminating System (IRIS)." However, it does not provide specific acceptance criteria or detailed reported device performance in a quantitative table format. It only states that the device "met design specifications and acceptance criteria" and "validated the ureteral trans-illumination capability."

    2. Sample size used for the test set and the data provenance:

    • Bench Testing: The document does not specify the sample size for bench testing.
    • Cadaver Testing: The document does not specify the sample size (number of cadavers or ureters) used for "cadaver testing."
    • Data Provenance: Not specified, but generally, such testing for a 510(k) submission would be conducted by the manufacturer (Stryker) or
      contracted labs within the U.S. or other regulated regions. The document implies this data is prospective, generated specifically for this submission.

    3. Number of experts used to establish the ground truth for the test set and their qualifications:

    Not applicable or not provided. This type of regulatory submission for a device without a diagnostic claim typically relies on engineering specifications and direct physical performance assessment, not expert interpretation of outputs against a ground truth from an expert consensus. The "validation" of trans-illumination in cadavers would be a direct observation, likely by the engineers and potentially surgeons involved in the study.

    4. Adjudication method for the test set:

    Not applicable or not provided. Adjudication methods like "2+1" or "3+1" are typically used in studies involving human interpretation (e.g., radiologists reviewing images) where disagreements need to be resolved. The tests described (bench and cadaver) are more focused on direct physical performance and engineering specifications.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and its effect size:

    No, an MRMC comparative effectiveness study was not done or reported in this document. MRMC studies are typically used to compare the performance of human readers with and without AI assistance for diagnostic tasks. This device is an illumination system, not a diagnostic algorithm that would be evaluated in such a study.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    This question is not directly applicable. The device is a physical illumination system (light source and ureteral kit), not a standalone algorithm. Its function is to provide illumination for human surgeons. The "standalone" performance would be its ability to emit light and trans-illuminate, which was assessed through bench and cadaver testing.

    7. The type of ground truth used:

    • For bench testing, the "ground truth" would be the device's design specifications and established engineering parameters.
    • For cadaver testing, the "ground truth" for "ureteral trans-illumination capability" would be the direct visual confirmation of the ureter being illuminated by the device in the cadaveric model. This is a direct physical observation, not an expert consensus or pathology report.

    8. The sample size for the training set:

    Not applicable. This device is a hardware system, not an AI/ML algorithm that requires a "training set" of data.

    9. How the ground truth for the training set was established:

    Not applicable, as there is no training set for this type of device.

    In summary:

    This 510(k) submission details the regulatory pathway for a medical device (an infrared illuminating system) by establishing its substantial equivalence to previously cleared devices. It describes that performance testing (bench and cadaver) was conducted to ensure the device met design specifications and validated its intended function. However, it does not provide detailed quantitative acceptance criteria, specific performance metrics, sample sizes for testing, or information relevant to AI algorithm studies (like MRMC, training sets, or expert consensus on ground truth) which are not applicable to this type of device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1